Steroid side chain modification gene and its application
A technology of steroidal compounds and compounds, applied in the field of biosynthesis of steroidal compounds, can solve problems such as limiting the biosynthesis of green glomycin compounds
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0157] The acquisition of embodiment 1 candidate gene
[0158] After whole-genome sequencing of Nodulisporium Sp. (65-12-7-1), which is rich in demethoxyviridin, the related functional genes were predicted by gene prediction software, and A gene cluster related to the synthesis of demethoxygreen glomycin was obtained ( figure 1 b), found 3 new genes VidF (polypeptide sequence as shown in SEQ ID NO: 1, nucleic acid sequence as shown in SEQ ID NO: 4), VidP (polypeptide sequence as shown in SEQ ID NO: 2, nucleic acid sequence as shown in SEQ ID NO: 2) ID NO: 5) and VidH (the polypeptide sequence is shown in SEQ ID NO: 3, the nucleic acid sequence is shown in SEQ ID NO: 6) as the final candidate research genes.
Embodiment 2
[0159] Example 2 gene knockout experiments proved that these three genes are closely related to the break and modification of the C17 side chain
[0160] The CRISPR / Cas9 knockout system was used to knock out the selected three genes (vidF, vidP, vidH) one by one, and the previously constructed Nodulisporium sp. (No.65-12-7-1) JN001 stably expressing the Cas9 protein Three stable knockout strains were constructed from strains (Zheng, Y.-M. et al. Development of a versatile and conventional technique forgene disruption in filamentous fungi based on CRISPR-Cas9 technology. Sci. Rep. 7, 9250, 2017) ΔvidF-JN1001, ΔvidP-JN1001 and ΔvidH-JN1001.
[0161] It can be seen from the results that ( figure 2 ), in the JN1001 strain of the control group, demethoxygreen glomycin (compound 1) was highly expressed, but in the knockout strains of the three genes, no demethoxygreen glomycin could be produced. Among them, in ΔvidF-JN1001, compound 7 or 6 was enriched, while in ΔvidP-JN1001, onl...
Embodiment 3
[0162] Example 3 VidF, VidP and VidH catalyze the cleavage and modification of the C17 side chain
[0163] In order to determine the functions of the three genes, recombinant VidF was purified in Escherichia coli ( Figure 4 ), carried out in vitro enzyme catalysis test, the results showed that VidF can catalyze the Bayer-Villiger oxidative rearrangement reaction (Baeyer-Villiger reaction) at the C17-C20 position of compound 7 (3-Dihydrovirone), thus obtaining compound 5 (Nodulisporiviridin N) ( Figure 5 ). Since VidP and VidH cannot be expressed in Escherichia coli, VidP and VidH were respectively introduced into Aspergillus oryzae A. Compound 5 (the catalytic product of VidF) is used as a substrate to produce compound 4 (Nodulisporiviridin M) with a hydroxyl group at the C17 position; VipH can further use compound 4 as a substrate to catalyze the conversion of the hydroxyl group at the C17 position to =O, Thereby obtaining compound 9 (Nodulisporiviridin K) ( Image 6 ),...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



